Linical Co., Ltd.

TSE:2183 Stok Raporu

Piyasa değeri: JP¥8.2b

Linical Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Linical has a total shareholder equity of ¥8.2B and total debt of ¥2.5B, which brings its debt-to-equity ratio to 30%. Its total assets and total liabilities are ¥19.0B and ¥10.8B respectively. Linical's EBIT is ¥546.0M making its interest coverage ratio -11.9. It has cash and short-term investments of ¥7.4B.

Anahtar bilgiler

30.0%

Borç/özkaynak oranı

JP¥2.46b

Borç

Faiz karşılama oranı-11.9x
NakitJP¥7.40b
EşitlikJP¥8.18b
Toplam yükümlülüklerJP¥10.80b
Toplam varlıklarJP¥18.98b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

There May Be Some Bright Spots In Linical's (TSE:2183) Earnings

May 22
There May Be Some Bright Spots In Linical's (TSE:2183) Earnings

Some Linical Co., Ltd. (TSE:2183) Shareholders Look For Exit As Shares Take 26% Pounding

Mar 08
Some Linical Co., Ltd. (TSE:2183) Shareholders Look For Exit As Shares Take 26% Pounding

Linical (TSE:2183) Is Paying Out A Larger Dividend Than Last Year

Feb 26
Linical (TSE:2183) Is Paying Out A Larger Dividend Than Last Year

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 2183's short term assets (¥13.0B) exceed its short term liabilities (¥8.3B).

Uzun Vadeli Yükümlülükler: 2183's short term assets (¥13.0B) exceed its long term liabilities (¥2.5B).

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 2183 has more cash than its total debt.

Borcun Azaltılması: 2183's debt to equity ratio has reduced from 100% to 30% over the past 5 years.

Borç Kapsamı: 2183's debt is well covered by operating cash flow (43.3%).

Faiz Kapsamı: 2183 earns more interest than it pays, so coverage of interest payments is not a concern.

Bilanço

Sağlıklı şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y